SCHEMBL13610457

SCHEMBL13610457

c1ccc2c(CSSSCc3ccc4nonc4c3)csc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.39
ALDH1A1 P00352 4/20 0.39
TSHR P16473 3/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 7/20 0.39
ALOX12 P18054 1/20 0.39
KMT2A Q03164 1/20 0.36
KCNJ1 P48048 1/20 0.34
KCNH2 Q12809 1/20 0.34
TP53 P04637 2/20 0.34
RXFP1 Q9HBX9 1/20 0.34
CHRNA7 P36544 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610434 0.81 FFAR2 (0.42) CYP2A6ALDH1A1HSD17B10SMN1; SMN2TP53
SCHEMBL4267991 0.79 CYP2A6 (0.60) CYP2A6ALDH1A1SMN1; SMN2TP53RXFP1
SCHEMBL13610461 0.75 SMN1; SMN2 (0.43) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610449 0.75 ALDH1A1 (0.46) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610439 0.74 ALDH1A1 (0.43) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610304 0.73 CYP2A6 (0.43) CYP2A6SMN1; SMN2TP53RXFP1MAPT
SCHEMBL13610454 0.71 ALDH1A1 (0.43) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610351 0.71 ALDH1A1 (0.48) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610526 0.70 SMN1; SMN2 (0.45) CYP2A6ALDH1A1TSHRMAPK1HSD17B10
SCHEMBL13610453 0.70 TDP1 (0.48) ALDH1A1TSHRALOX15MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742635-B1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES INC (US) 2018-03-07 EP disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS CYP2A6 2406/4885ALDH1A1 285/4885TSHR 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.